Integral Diagnostics Limited (ASX:IDX)

Market Cap	961.60M
Revenue (ttm)	627.22M
Net Income (ttm)	4.67M
Shares Out	372.71M
EPS (ttm)	0.02
PE Ratio	171.28
Forward PE	20.28
Dividend	0.07 (2.53%)
Ex-Dividend Date	Aug 29, 2025

Volume	558,622
Average Volume	811,836
Open	2.600
Previous Close	2.580
Day's Range	2.490 - 2.600
52-Week Range	1.910 - 3.180
Beta	0.17
RSI	49.29
Earnings Date	Nov 25, 2025

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,025
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX